What to know before starting tirzepatide or semaglutide
Before starting tirzepatide (Mounjaro, Zepbound) or semaglutide (Ozempic, Wegovy), know who the labels exclude, how the dose builds and which side effects come first. US labels exclude anyone with a personal or family history of medullary thyroid cancer or MEN 2. Doses rise in 4-week steps, and nausea affected 25% to 44% in US-label weight trials.
Who should not take tirzepatide or semaglutide?
The US Zepbound and Wegovy labels rule out anyone with a personal or family history of medullary thyroid cancer (MTC) or MEN 2.12
The UK and EU Mounjaro and Wegovy labels do not list this exclusion. The only reason they list for not using either medicine is an allergy to it or its ingredients.3456
MEN 2 stands for multiple endocrine neoplasia syndrome type 2.1 Both labels also rule out anyone who has had a serious allergic reaction to the medicine or its ingredients. They report anaphylaxis and angioedema (swelling under the skin) with each medicine.12
The US Zepbound label says weight loss is not recommended in pregnancy, and to stop when a pregnancy is recognised.1 The UK and EU Mounjaro labels say to stop tirzepatide at least 1 month before a planned pregnancy.35 The US, UK and EU Wegovy labels set at least 2 months for semaglutide, because it stays in the body a long time.246
How does the starting dose work?
Both medicines start on a low dose for 4 weeks, and the US Wegovy label says its dose steps reduce the risk of stomach side effects.12
The US Zepbound label starts at 2.5 mg once a week for 4 weeks, then 5 mg. It says 2.5 mg is for starting treatment and is not approved as a maintenance dose. Further rises come in 2.5 mg steps, after at least 4 weeks on the current dose.1
The US Wegovy injection label starts at 0.25 mg a week. The dose rises every 4 weeks, through 0.5 mg and 1 mg, to 1.7 mg in weeks 13 to 16. For weight loss in adults, the maintenance dose is 1.7 mg or 2.4 mg.2
If a dose is not tolerated, the US Wegovy label suggests delaying the next step by 4 weeks. Wegovy tablets start at 1.5 mg once a day.2
Which side effects are most common at the start?
Stomach and gut side effects are the most common, and in both US labels they happened mostly while the dose was being increased.12
In the US Zepbound weight trials, nausea affected 25% to 29% of people across doses, against 8% on placebo. Diarrhoea affected 19% to 23% (8% on placebo) and constipation 11% to 17% (5% on placebo).1
In the US Wegovy 2.4 mg injection trials, nausea affected 44% against 16% on placebo. Diarrhoea affected 30% against 16%, and constipation 24% against 11%.2
Side effects led 4.8% to 6.7% of people on Zepbound to stop for good, against 3.4% on placebo, mostly in the first few months.1 On Wegovy 2.4 mg injection, the figures were 6.8% and 3.2%.2 Both US labels warn that dehydration from these side effects can harm the kidneys, and advise steps to avoid losing fluid.12
Each country’s GLP-1 side effects guide goes further, starting with the side effects guide for Australia, and every one is linked under In your country.
Which medicines and plans do the labels flag before you start?
The labels flag diabetes medicines that can cause low blood sugar, the contraceptive pill with tirzepatide, eye disease from diabetes, and planned surgery.12
Both US labels say the risk of low blood sugar rises with insulin or a sulfonylurea (a type of diabetes tablet). They say to consider lowering those doses when starting.12
The US Zepbound label says tirzepatide may make the contraceptive pill work less well. It advises switching to a non-oral method, or adding a barrier method, for 4 weeks after starting and 4 weeks after each dose increase.1 The UK Mounjaro label gives the same advice, citing limited data in people with obesity or overweight.3
Both US labels say diabetic eye disease (retinopathy) has briefly worsened when blood sugar improved quickly, so people with it should be monitored.12 Both US labels also warn of acute pancreatitis and gallbladder problems, including gallstones, and ask patients to report their symptoms.12 They also cite rare reports of people breathing in stomach contents under general anaesthesia or deep sedation. Both ask patients to tell their healthcare provider about any planned surgery or procedure.12
What do people on GLP-1 medicines report about starting?
From public patient forums: 2,687 Reddit threads in r/Zepbound, r/WegovyWeightLoss, r/Mounjaro, r/mounjarouk, r/Semaglutide and r/Ozempic, read October 2025 to October 2026. Personal reports, not medical evidence.
What people describe
- Matches the label Several say the starter dose did little, with effects building over weeks or only at higher doses. The US Zepbound label calls 2.5 mg a starting dose, not approved for maintenance.1
- Matches the label A few describe nausea that came back or began after a dose increase. The US Zepbound label says most nausea came during dose increases and eased over time.1
- Matches the label Several name constipation as an ongoing complaint. It affected 11% to 17% on Zepbound in the US trials, against 5% on placebo.1
- Matches the label Several describe tiredness in the first days after a shot. Fatigue affected 5% to 7% on Zepbound in the US trials, against 3% on placebo.1
Advice people share
- Matches the label Many advise drinking more than feels necessary. Both US labels advise steps to avoid losing fluid, because dehydration can harm the kidneys.12
- Matches the label Several advise giving each dose step at least 4 weeks. The US Zepbound label sets at least 4 weeks on the current dose before each rise.1
- Label says otherwise Several posts describe doses people chose for themselves, such as split or partial doses, and a few describe skipping steps. The US Zepbound label starts at 2.5 mg for 4 weeks and raises the dose in 2.5 mg steps after at least 4 weeks.1
In your country
The 4-week dose steps are the same in the labels we opened. The thyroid-cancer exclusion, the time to stop before pregnancy and the contraceptive-pill advice differ by label.135
Australia
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.
Label: We did not open Australia’s Product Information, so this page relies on the US, UK and EU labels.
Emergency number: 000
Canada
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.
Label: We did not open Canada’s Product Monographs, so this page relies on the US, UK and EU labels.
Emergency number: 911
France
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).
Label: The EU Mounjaro and Wegovy labels list only an allergy to the medicine or its ingredients as a reason not to use it. They do not list medullary thyroid cancer or MEN 2.56 The EU Mounjaro label says to stop tirzepatide at least 1 month before a planned pregnancy. It recommends contraception while on tirzepatide, and says the contraceptive pill dose needs no change, with no 4-week barrier-method step.5
Emergency number: 15 or 112
Germany
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.
Label: The EU Mounjaro and Wegovy labels list only an allergy to the medicine or its ingredients as a reason not to use it. They do not list medullary thyroid cancer or MEN 2.56 The EU Mounjaro label says to stop tirzepatide at least 1 month before a planned pregnancy. It recommends contraception while on tirzepatide, and says the contraceptive pill dose needs no change, with no 4-week barrier-method step.5
Emergency number: 112
India
Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).
Label: We did not open an Indian label, so this page relies on the US, UK and EU labels.
Emergency number: 112
Saudi Arabia
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.
Label: We did not open a Saudi label, so this page relies on the US, UK and EU labels.
Emergency number: 997 or 911
United Arab Emirates
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.
Label: We did not open a UAE label, so this page relies on the US, UK and EU labels.
Emergency number: 998 for an ambulance, or 999
United Kingdom
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.
Label: The UK Mounjaro and Wegovy labels list only an allergy to the medicine or its ingredients as a reason not to use it. They do not list medullary thyroid cancer or MEN 2.34 The UK Mounjaro label says to stop tirzepatide at least 1 month before a planned pregnancy. The UK Wegovy injection label calls for a decision on continuing if weight loss is under 5% after 6 months. The UK Mounjaro label sets the same check 6 months after reaching the highest tolerated dose.34
Emergency number: 999
United States
Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).
Label: The answer above applies.
Emergency number: 911
Stop using Wegovy and call your prescriber right away if you have severe pain in your stomach area that will not go away, with or without nausea or vomiting. The US Wegovy Medication Guide links this pain to pancreatitis.2 The guide also says to tell them right away about nausea, vomiting or diarrhoea that does not go away.2
Read the full picture
Related questions
Sources
- US Zepbound (tirzepatide) prescribing information, Eli Lilly, revised August 2026. pi.lilly.com
- US Wegovy (semaglutide) injection and tablets prescribing information and Medication Guide, Novo Nordisk, revised June 2026, on DailyMed. dailymed.nlm.nih.gov
- UK Mounjaro KwikPen (tirzepatide) Summary of Product Characteristics, on the electronic Medicines Compendium. medicines.org.uk
- UK Wegovy 2.4 mg FlexTouch (semaglutide) Summary of Product Characteristics, on the electronic Medicines Compendium. medicines.org.uk
- EU Mounjaro (tirzepatide) product information, European Medicines Agency. ema.europa.eu
- EU Wegovy (semaglutide) product information, European Medicines Agency. ema.europa.eu
- American College of Emergency Physicians. Know When to Go. emergencyphysicians.org
Last checked Nov 9, 2026 · Next review due Nov 9, 2027 · Report an error
How this answer was made. Written by the GLP Guidebook team from the sources above, all checked on Nov 9, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write